USMLE Step 1 & 2 Pulmonary Embolism
Last updated: May 2, 2026
Pulmonary Embolism questions are one of the highest-leverage areas to study for the USMLE Step 1 & 2. This guide breaks down the rule, the elements you need to recognize, the named traps that catch most students, and a memory aid that scales to test day. Read it once, then practice the same sub-topic adaptively in the app.
The rule
Pulmonary embolism (PE) is obstruction of pulmonary arterial flow by thrombus (almost always from a lower-extremity DVT), causing V/Q mismatch, hypoxemia, and right ventricular strain. Diagnostic workup is driven by pretest probability (Wells score) and hemodynamic stability: low probability → PERC or D-dimer to rule out; intermediate/high probability → CT pulmonary angiography (CTPA); hemodynamically unstable → bedside echo and empiric anticoagulation, with thrombolysis if massive. Initial treatment is anticoagulation for all confirmed PEs, escalated to systemic thrombolysis or embolectomy for massive (hypotensive) PE.
Elements breakdown
Risk Factors (Virchow's Triad)
Conditions predisposing to venous thromboembolism via stasis, endothelial injury, or hypercoagulability.
- Stasis: immobilization, recent surgery, long travel
- Injury: trauma, central lines, recent fracture
- Hypercoagulability: malignancy, OCPs, pregnancy, Factor V Leiden, antiphospholipid syndrome
Wells Criteria for PE (Pretest Probability)
Validated clinical decision rule estimating probability of PE before imaging.
- Clinical signs of DVT: 3 points
- PE most likely diagnosis: 3 points
- HR > 100: 1.5 points
- Immobilization/surgery in past 4 weeks: 1.5 points
- Prior DVT/PE: 1.5 points
- Hemoptysis: 1 point
- Malignancy: 1 point
- Score > 4: PE likely → CTPA; ≤ 4: PE unlikely → D-dimer
PERC Rule (Rule-Out)
Eight criteria; if all negative AND clinical gestalt is low risk, no further workup needed.
- Age < 50, HR < 100, SaO₂ ≥ 95%
- No hemoptysis, no estrogen use, no prior VTE
- No recent surgery/trauma, no unilateral leg swelling
Diagnostic Modalities
Imaging and labs used to confirm or exclude PE.
- D-dimer: highly sensitive, poor specificity — only useful to rule out
- CTPA: gold standard in stable patients
- V/Q scan: alternative if contrast contraindicated (renal failure, pregnancy 1st choice)
- Bedside echo: RV dilation/strain in unstable patients
- Lower-extremity duplex: confirms DVT source
Common examples:
- Westermark sign (oligemia) and Hampton hump (wedge infarct) on CXR are classic but insensitive
PE Severity Classification
Stratification that determines treatment intensity.
- Massive: SBP < 90 or shock → thrombolysis
- Submassive: RV strain on echo or elevated troponin/BNP, normotensive → consider thrombolysis
- Low-risk: normotensive, no RV dysfunction → anticoagulation alone
Treatment
Anticoagulation backbone with escalation for unstable disease.
- First-line: DOAC (apixaban, rivaroxaban) or LMWH bridge to warfarin
- Massive PE: tPA (alteplase) systemic thrombolysis
- Contraindication to anticoagulation: IVC filter
- Cancer-associated VTE: LMWH or DOAC, indefinite duration
Common patterns and traps
The Pretest-Probability Gateway
USMLE PE questions reliably hinge on whether you applied Wells (or gestalt) BEFORE choosing the test. The exam punishes reflexive D-dimer ordering in high-probability patients and reflexive CTPA ordering in low-probability patients. The right answer almost always reflects matching test intensity to clinical probability.
A distractor offers D-dimer in a tachycardic post-op patient with leg swelling — wrong because pretest probability is already high; CTPA is the correct next step.
The Unstable-Patient Override
When a patient is hypotensive and PE is suspected, the standard diagnostic algorithm is suspended. You start empiric anticoagulation, get a bedside echo (looking for RV dilation or McConnell sign), and proceed to thrombolysis if confirmed or if the patient is in arrest. CTPA is dangerous to attempt in a crashing patient and is not the answer here.
A distractor offers 'obtain CTPA' in a patient with BP 70/40 and suspected PE — wrong because empiric heparin and bedside echo come first.
The Pregnant Patient Pathway
In pregnancy, contrast and radiation concerns shift the algorithm. Workup typically starts with bilateral lower-extremity duplex; if positive, treat without further imaging. If negative and PE still suspected, V/Q scan is preferred over CTPA (lower fetal radiation in 1st trimester debates aside). Warfarin is teratogenic — LMWH is the anticoagulant of choice.
A distractor offers warfarin or a DOAC for VTE in a pregnant patient — wrong because LMWH (enoxaparin) is the correct answer.
The Provoked-vs-Unprovoked Duration Trap
Anticoagulation duration depends on whether PE was provoked (transient risk factor like surgery: 3 months) or unprovoked/recurrent/cancer-associated (extended or indefinite). Exam questions test whether you correctly classify the inciting event and pick the matching duration.
A distractor offers '6 months of anticoagulation' for an unprovoked PE — wrong because indefinite anticoagulation is recommended given high recurrence risk.
The CXR/ECG Distractor
Classic 'buzzword' findings (Westermark, Hampton hump on CXR; S1Q3T3 on ECG) appear in roughly 10-20% of PEs and are insensitive. The exam may include them to test whether you over-rely on classic findings or correctly recognize sinus tachycardia as the most common ECG finding.
A question states 'ECG shows sinus tachycardia and CXR is normal' — this does not rule out PE; pretest probability still drives the workup.
How it works
Imagine a 58-year-old woman returns from a 12-hour flight with sudden pleuritic chest pain, dyspnea, and HR 112. You build a Wells score: tachycardia (1.5), recent immobilization (1.5), PE most likely (3) = 6 points → PE likely. You skip D-dimer (it would be useless at this pretest probability) and go straight to CTPA, which shows a segmental filling defect. Her BP is 128/78 and echo shows no RV strain — this is low-risk PE, so you start apixaban without thrombolysis. Contrast this with a patient who arrives with PE and BP 78/40: that patient gets immediate tPA, because mortality from massive PE is driven by acute RV failure, and the bleeding risk of lytics is justified.
Worked examples
Which of the following is the most appropriate next step in management?
- A Obtain a D-dimer level
- B Obtain CT pulmonary angiography ✓ Correct
- C Obtain a ventilation/perfusion scan
- D Begin systemic thrombolysis with alteplase
Why B is correct: This patient's Wells score is high (recent surgery 1.5, tachycardia 1.5, clinical signs of DVT 3, PE most likely diagnosis 3 = 9 points), placing her firmly in the 'PE likely' category. With high pretest probability, D-dimer is not useful — a positive result does not change management, and a negative result has insufficient negative predictive value at this probability. CTPA is the gold-standard confirmatory test in a hemodynamically stable patient and is the correct next step.
Why each wrong choice fails:
- A: D-dimer is only useful to rule out PE in low/intermediate pretest probability. With Wells > 4, ordering D-dimer wastes time and resources because a positive result requires CTPA anyway. (The Pretest-Probability Gateway)
- C: V/Q scan is reserved for patients with contraindications to CTPA (severe renal failure, contrast allergy, pregnancy). This patient has no such contraindication, so CTPA is preferred.
- D: Thrombolysis is reserved for confirmed massive PE with hemodynamic instability (SBP < 90). This patient is normotensive, and PE has not yet been confirmed — empiric thrombolysis here would expose her to unjustified bleeding risk. (The Unstable-Patient Override)
Which of the following is the most appropriate next step in management?
- A Order CT pulmonary angiography to confirm the diagnosis
- B Place an inferior vena cava filter
- C Administer intravenous alteplase ✓ Correct
- D Initiate apixaban orally
Why C is correct: This patient has massive PE: hemodynamic instability (SBP 76), echocardiographic evidence of acute RV strain in a high-pretest-probability cancer patient with sudden hypoxemia, and biomarker evidence of myocardial injury. Mortality of untreated massive PE exceeds 50%, and systemic thrombolysis with alteplase is lifesaving by rapidly lysing the obstructing clot and offloading the failing RV. He should also receive empiric anticoagulation, but the immediate priority is thrombolysis.
Why each wrong choice fails:
- A: Transporting a hemodynamically unstable, hypoxic patient to CT scanner is dangerous and delays lifesaving treatment. The bedside echo already provides sufficient evidence of acute RV strain to justify empiric thrombolysis in this clinical context. (The Unstable-Patient Override)
- B: IVC filters are reserved for patients with confirmed VTE who have absolute contraindications to anticoagulation (active bleeding) or recurrent PE on therapeutic anticoagulation. They do not address the existing pulmonary clot causing this patient's shock.
- D: Oral apixaban is appropriate for stable PE but is far too slow to act in a patient in obstructive shock. The acute RV failure requires immediate clot lysis, not gradual anticoagulation.
Which of the following is the most appropriate treatment?
- A Subcutaneous enoxaparin ✓ Correct
- B Oral warfarin titrated to INR 2-3
- C Oral rivaroxaban
- D Inferior vena cava filter placement
Why A is correct: This pregnant patient has a confirmed proximal DVT with clinical findings highly suggestive of concomitant PE. In pregnancy, low-molecular-weight heparin (enoxaparin) is the anticoagulant of choice because it does not cross the placenta and has a predictable dose-response. Confirmatory imaging for PE is not strictly required when treatment for the established DVT will be the same; she needs immediate therapeutic anticoagulation.
Why each wrong choice fails:
- B: Warfarin is teratogenic, particularly in the first trimester (warfarin embryopathy: nasal hypoplasia, stippled epiphyses) and increases fetal bleeding risk throughout pregnancy. It is contraindicated for VTE treatment in pregnancy. (The Pregnant Patient Pathway)
- C: DOACs including rivaroxaban and apixaban are not recommended in pregnancy due to limited safety data and known placental transfer. LMWH remains the standard of care. (The Pregnant Patient Pathway)
- D: IVC filters are reserved for patients who cannot receive anticoagulation. This patient has no contraindication to LMWH, so a filter is not indicated and would expose her to additional procedural risk.
Memory aid
Wells > 4 → CTPA. Wells ≤ 4 → D-dimer. Unstable + suspected PE → echo + empiric heparin + lytics if massive. The mantra: 'Pretest probability picks the test.'
Key distinction
Massive vs. submassive PE. Massive = hemodynamic instability (SBP < 90) → thrombolysis is lifesaving. Submassive = normotensive with RV dysfunction or positive cardiac biomarkers → thrombolysis is case-by-case, not automatic. Mislabeling submassive as massive leads candidates to choose tPA when anticoagulation alone is the right answer.
Summary
Use Wells to set pretest probability, CTPA to confirm in stable patients, and reserve thrombolysis for hemodynamically unstable (massive) PE — anticoagulation is the floor for everyone else.
Practice pulmonary embolism adaptively
Reading the rule is the start. Working USMLE Step 1 & 2-format questions on this sub-topic with adaptive selection, watching your mastery score climb in real time, and seeing the items you missed return on a spaced-repetition schedule — that's where score lift actually happens. Free for seven days. No credit card required.
Start your free 7-day trialFrequently asked questions
What is pulmonary embolism on the USMLE Step 1 & 2?
Pulmonary embolism (PE) is obstruction of pulmonary arterial flow by thrombus (almost always from a lower-extremity DVT), causing V/Q mismatch, hypoxemia, and right ventricular strain. Diagnostic workup is driven by pretest probability (Wells score) and hemodynamic stability: low probability → PERC or D-dimer to rule out; intermediate/high probability → CT pulmonary angiography (CTPA); hemodynamically unstable → bedside echo and empiric anticoagulation, with thrombolysis if massive. Initial treatment is anticoagulation for all confirmed PEs, escalated to systemic thrombolysis or embolectomy for massive (hypotensive) PE.
How do I practice pulmonary embolism questions?
The fastest way to improve on pulmonary embolism is targeted, adaptive practice — working questions that focus on your specific weak spots within this sub-topic, getting immediate feedback, and revisiting items you missed on a spaced-repetition schedule. Neureto's adaptive engine does this automatically across the USMLE Step 1 & 2; start a free 7-day trial to see your sub-topic mastery climb in real time.
What's the most important distinction to remember for pulmonary embolism?
Massive vs. submassive PE. Massive = hemodynamic instability (SBP < 90) → thrombolysis is lifesaving. Submassive = normotensive with RV dysfunction or positive cardiac biomarkers → thrombolysis is case-by-case, not automatic. Mislabeling submassive as massive leads candidates to choose tPA when anticoagulation alone is the right answer.
Is there a memory aid for pulmonary embolism questions?
Wells > 4 → CTPA. Wells ≤ 4 → D-dimer. Unstable + suspected PE → echo + empiric heparin + lytics if massive. The mantra: 'Pretest probability picks the test.'
What's a common trap on pulmonary embolism questions?
Ordering D-dimer in a high-pretest-probability patient (it does not rule in, and a positive result does not change management)
What's a common trap on pulmonary embolism questions?
Withholding empiric anticoagulation while waiting for CTPA in unstable patients
Ready to drill these patterns?
Take a free USMLE Step 1 & 2 assessment — about 25 minutes and Neureto will route more pulmonary embolism questions your way until your sub-topic mastery score reflects real improvement, not luck. Free for seven days. No credit card required.
Start your free 7-day trial